Innovstone Therapeutics Limited
Clinical trials sponsored by Innovstone Therapeutics Limited, explained in plain language.
-
New pill aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis study tests an experimental tablet called SYH2059 in 156 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing harder. Participants will receive either the drug or a placebo to see if it can slow the decline in lung function. The…
Phase: PHASE2 • Sponsor: InnovStone Therapeutics Limited • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New inhaled drug SYH2059 begins first human safety tests
Knowledge-focused Not yet recruitingThis Phase 1 trial will test the safety and tolerability of an inhaled drug called SYH2059 in 84 healthy adults. Participants will receive either single or multiple doses of the drug or a placebo. The study aims to understand how the body processes the drug and whether it causes …
Phase: PHASE1 • Sponsor: InnovStone Therapeutics Limited • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:57 UTC